Related Experiment Videos
Metallothionein in amyotrophic lateral sclerosis
P A Sillevis Smitt1, T P Mulder, H W Verspaget
1Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands.
Biological Signals
|July 1, 1994
Summary
Metallothionein (MT) levels are elevated in ALS organs like the liver and kidney, but not serum. This suggests potential increased metal exposure or oxidative stress in amyotrophic lateral sclerosis (ALS).
Area of Science:
- Neuroscience
- Toxicology
- Biochemistry
Background:
- Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting motor neurons.
- Familial ALS is linked to mutations in copper, zinc superoxide dismutase, but the cause of sporadic ALS remains unknown.
- Metals and oxidative stress are potential factors in ALS pathogenesis.
Purpose of the Study:
- To investigate the role of metals in ALS by examining metallothionein (MT) levels.
- To determine if MT levels in ALS organs and serum differ from controls.
Main Methods:
- Analysis of metallothionein (MT) levels in ALS patient organs (liver, kidney, spinal cord) and serum.
- Comparison of MT levels in ALS patients versus controls.
Main Results:
- Significantly increased MT levels were found in the liver and kidney of ALS patients.
- Serum MT levels in ALS patients were comparable to controls.
- MT expression was observed in gray matter protoplasmic astrocytes within the spinal cord of ALS patients.
Conclusions:
- Elevated MT levels in ALS organs suggest increased metal exposure or oxidative stress.
- The discrepancy between organ and serum MT levels indicates localized responses in ALS.
- Further research is needed to elucidate the precise role of metals and MT in ALS etiology.